These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 404392)

  • 21. Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing.
    Laurenzo D; Mousa SA
    Acta Trop; 2011 Jul; 119(1):5-10. PubMed ID: 21515239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

  • 23. Some observations on the genetics of isoniazid resistance in the tubercle bacilli.
    David HL; Newman CM
    Am Rev Respir Dis; 1971 Oct; 104(4):508-15. PubMed ID: 4999282
    [No Abstract]   [Full Text] [Related]  

  • 24. Isoniazid-resistant mutants of Mycobacterium tuberculosis H37RV: uptake of isoniazid and the properties of NADase inhibitor.
    Sriprakash KS; Ramakrishnan T
    J Gen Microbiol; 1970 Jan; 60(1):125-32. PubMed ID: 4992269
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
    Casal M; Gutierrez J; González J; Ruiz P
    Chemioterapia; 1987 Dec; 6(6):437-9. PubMed ID: 3124964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain.
    González N; Torres MJ; Aznar J; Palomares JC
    Tuber Lung Dis; 1999; 79(3):187-90. PubMed ID: 10656117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis.
    Ando H; Miyoshi-Akiyama T; Watanabe S; Kirikae T
    Mol Microbiol; 2014 Feb; 91(3):538-47. PubMed ID: 24354762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of S315T mutation in the katg gene as a strategy for identification of isoniazid-resistant Mycobacterium tuberculosis in a reference laboratory].
    Romay Z; Arráiz N; Fuenmayor A; Ramírez C; Rojas L; París R
    Rev Chilena Infectol; 2012 Dec; 29(6):607-13. PubMed ID: 23412028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2005 Oct; 251(1):19-22. PubMed ID: 16143463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Secondary resistance of tubercle bacilli to antibiotics].
    Kurdziel Z
    Przegl Lek; 1966; 22(10):645-8. PubMed ID: 4960191
    [No Abstract]   [Full Text] [Related]  

  • 31. Quinonoid and phenazine compounds: synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis.
    Carneiro PF; Pinto Mdo C; Coelho TS; Cavalcanti BC; Pessoa C; de Simone CA; Nunes IK; de Oliveira NM; de Almeida RG; Pinto AV; de Moura KC; da Silva PA; da Silva Júnior EN
    Eur J Med Chem; 2011 Sep; 46(9):4521-9. PubMed ID: 21820768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice].
    Matsumiya T; Freerksen E; Rosenfeld M
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):14-29. PubMed ID: 4320557
    [No Abstract]   [Full Text] [Related]  

  • 33. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.
    Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M
    J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of emerging isoniazid resistance to Mycobacterium tuberculosis in Korea.
    Hong YP; Jin BW; Kim SJ
    Aviat Space Environ Med; 1988 Feb; 59(2):185. PubMed ID: 3125824
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on mutation of isoniazid resistant genes in M. tuberculosis].
    Yao MH; Lou YH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):195-6. PubMed ID: 12536677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant prevention concentration of isoniazid, rifampicin and rifabutin against Mycobacterium tuberculosis.
    Rodríguez JC; Cebrián L; Ruiz M; López M; Royo G
    Chemotherapy; 2005 May; 51(2-3):76-9. PubMed ID: 15870500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental tuberculosis produced by phthivazid-resistant mutants of the culture H 37 Rv].
    Zemskova ZS; Sergeev VV
    Probl Tuberk; 1967; 45(9):77-82. PubMed ID: 4974608
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-resistance in M. tuberculosis and other mycobacteria.
    David HL
    Clin Chest Med; 1980 May; 1(2):227-30. PubMed ID: 6794975
    [No Abstract]   [Full Text] [Related]  

  • 39. [Isoniazid effect despite isoniazid resistance? An experimental study].
    Freerksen E; Rosenfeld M; Matsumiya T
    Prax Pneumol; 1969 Jul; 23(7):450-64. PubMed ID: 4980077
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.